Literature DB >> 31713213

Antibiotics: From the Beginning to the Future: Part 1.

Nancy Khardori1, Cecilia Stevaux2, Kathryn Ripley2.   

Abstract

The first written record of intervention against what later came to be known as an infectious disease was in the early seventeenth century by a Buddhist nun. She dried 3 to 4 wk old scabs from patients with mild smallpox and asked well people to inhale the powder. More than a century later in 1796, Edward Jenner described vaccination against smallpox by using cowpox that later was found to be caused by cowpox virus which is non-pathogenic for humans. Another century later in 1890, Robert Koch published the Koch's Postulates allowing the study of pathogenic bacteria and subsequently the study of agents to fight them. The first chemical cure for disease was reported by Paul Erhlich in 1909 in the form of an arsenic compound to treat syphilis. One hundred and ten years since then a lot has happened in the area of preventing and treating infectious diseases with significant contribution to increase in human lifespan. This is the only area of medicine in which treatment (antimicrobial agent) is used to eradicate a replicating biological agent inside the human host. The potential of this second biological agent to mutate under the selection pressure of antibiotics making them resistant was recognized in the 1940s. But the indiscriminate use of antibiotics for over 70 y has led to the present crisis of resistance in major pathogens with increased morbidity and mortality. In this review, we have incorporated all the possible avenues that might be useful in the future. However, none is more important than relearning the judicious use of antibiotics based on microbiology, pharmacology, and genetics.

Entities:  

Keywords:  Antibiotic stewardship; Antibiotics; Antimicrobial peptides; Bacteriophages; Resistance

Mesh:

Substances:

Year:  2019        PMID: 31713213     DOI: 10.1007/s12098-019-03087-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  10 in total

1.  A novel antimicrobial agent joins the battle against resistant bacteria.

Authors:  R C Moellering
Journal:  Ann Intern Med       Date:  1999-01-19       Impact factor: 25.391

2.  Howard Florey, Alexander Fleming and the fairy tale of penicillin.

Authors:  Peter D Goldsworthy; Alexander C McFarlane
Journal:  Med J Aust       Date:  2002-02-18       Impact factor: 7.738

Review 3.  Antibiotics--past, present, and future.

Authors:  Nancy Khardori
Journal:  Med Clin North Am       Date:  2006-11       Impact factor: 5.456

4.  New Societal Approaches to Empowering Antibiotic Stewardship.

Authors:  Brad Spellberg; Arjun Srinivasan; Henry F Chambers
Journal:  JAMA       Date:  2016 Mar 22-29       Impact factor: 56.272

5.  5300 years ago, the Ice Man used natural laxatives and antibiotics.

Authors:  L Capasso
Journal:  Lancet       Date:  1998-12-05       Impact factor: 79.321

Review 6.  Antimicrobial therapy: toward the future.

Authors:  R Ellis; D Pillay
Journal:  Br J Hosp Med       Date:  1996 Aug 21-Sep 3

7.  Antibiotics: past, present, and future. Unearthing nature's magic bullets.

Authors:  D Hoel; D N Williams
Journal:  Postgrad Med       Date:  1997-01       Impact factor: 3.840

8.  Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Authors:  Matthew E Wand; Lucy J Bock; Laura C Bonney; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 9.  The penicillins.

Authors:  A J Wright
Journal:  Mayo Clin Proc       Date:  1999-03       Impact factor: 7.616

10.  In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

Authors:  R N Jones; M S Barrett; M E Erwin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

  10 in total
  2 in total

1.  Resistance to Antibacterial Agents: Foregone Conclusion - What's Next?

Authors:  Chand Wattal; Nancy Khardori
Journal:  Indian J Pediatr       Date:  2019-12-11       Impact factor: 1.967

2.  Extended-Spectrum ß-Lactamase-Producing Escherichia coli in Conventional and Organic Pig Fattening Farms.

Authors:  Katharina Meissner; Carola Sauter-Louis; Stefan E Heiden; Katharina Schaufler; Herbert Tomaso; Franz J Conraths; Timo Homeier-Bachmann
Journal:  Microorganisms       Date:  2022-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.